ArticleBiological psychiatry global open science2026
Efficacy and Safety of the Selective, Brain-Penetrant P2X7 Receptor Antagonist JNJ-55308942 (Zanvipixant) in Bipolar Depression: A Phase 2a Study.
James A Palmer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.